Safety, Tolerability, Immunological and Clinical Efficacy of Multiple Subcutaneous Doses of DiaPep277 in Latent Autoimmune Diabetes in Adults (LADA)

This study has been terminated.

Study NCT00058981 Information provided by DeveloGen Israel, Ltd.

First Received: April 15, 2003 Last Updated: March 18, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been terminated.
Study Completion Date:	May 2007
Primary Completion Date:	March 2007 (Final data collection date for primary outcome measure)